been ongoing since 2013. A limitation to the generalizability of our findings may be that 3 clinical trials of early CP motor interventions have been ongoing since 2013. Administration of… Click to show full abstract
been ongoing since 2013. A limitation to the generalizability of our findings may be that 3 clinical trials of early CP motor interventions have been ongoing since 2013. Administration of magnesium is a resource-intensive intervention that is not without risks. Given our findings, the role of magnesium for fetal neuroprotection may need reevaluation at the national level. Physicians should evaluate the longterm impact of clinical interventions, a mandate not unique to magnesium trials for prevention of CP. Many industries have developed lean thinking tools, such as the plan-do-checkadjust cycle, that can drive evaluation of health care recommendations adopted following large randomized trials.
Click one of the above tabs to view related content.